Supreme Court: SC/ST Act Does Not Apply to Alleged Casteist Abuse Inside a Private House  ||  Supreme Court: Frictionless Relationship Between the Bar and the Bench Strengthens Justice Delivery  ||  Delhi High Court: Eviction From Jhuggis With Rehabilitation Does Not Violate Article 21  ||  Madras HC: Courts Cannot Remain Silent When Single Disputed Vote Could Determine Government’s Fate  ||  Allahabad HC Blamed State and Police For Delays and Ordered Reforms to Tackle “Tarikh Pe Tarikh”  ||  Supreme Court: Banks Cannot Invoke IBC Against Debtors For Builder-Linked Loans  ||  Supreme Court: Non-Disclosure of Failed Candidates’ Marks Does Not Imply They Passed Exams  ||  Supreme Court: Murder Accused Cannot Inherit Property of the Person Allegedly Killed  ||  Supreme Court: Delay in Deposit Does Not Automatically Cancel Contracts under Specific Relief Act  ||  SC: Railways is Treated as a Consumer under the Electricity Act, Not a Distribution Licensee    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved